Artal Participations S.a r.l.
- SEC CIK
- 0002048403
In the past year, 1 open-market purchase filing worth $2.00M and 1 sale filing worth $270.9M.
Current role at each company
- CAVA Cava Group, Inc.Directoras of Jun 17, 2026
- LXRX Lexicon Pharmaceuticals, Inc.Director, 10% Owneras of May 8, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $2.00M
- 1 filing
- Sold
- $270.9M
- 1 filing
- Net
- −$268.9M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Artal Participations S.a r.l. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CAVA Cava Group, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 (view filing)4:15 PM ET | Jun 15 | 2 days | Artal Group S.A. and 6 othersDirector | SSale | −3.00M | $90.30 | −$270.9M | −31.6%6.51M after |
LXRX Lexicon Pharmaceuticals, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 (view filing)4:25 PM ET | Feb 2 | 2 days | Debbane Raymond and 8 othersDirector | PPurchase | +1.54M | $1.30 | +$2.00M | New position1.54M after |